Heron Therapeutics | Koszty Operacyjne





Koszty Operacyjne Zmiana Data
ALKERMES USD 1.73B 1.44B 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Amarin USD 51.37M 14.6M 2025-09
ANI Pharmaceuticals USD 505.82M 309.62M 2025-09
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 223.22M 10.86M 2025-12
Eisai JPY 199.9B 16.22B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Heron Therapeutics USD 38.47M 4M 2024-09
Insmed USD 403.69M 42.4M 2025-09
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
Merck USD 10.16B 558M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 555.6M 13.7M 2025-09
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 166.36M 4.5M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Surmodics USD -245.35M 363.49M 2024-09
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
Veracyte USD 108.76M 7.09M 2025-09
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09


Heron Therapeutics Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.